We are live on ! Find out more
BI

BlueSpruce Investments Portfolio holdings

AUM $631M
1-Year Est. Return 11.83%
This Fund
S&P 500
This Quarter Est. Return
-4.22%
1 Year Est. Return
+11.83%
3 Year Est. Return
+47.68%
5 Year Est. Return
+43.54%
10 Year Est. Return
+203.66%
AUM
$5.49B
AUM Growth
-$320M
Cap. Flow
-$66.2M
Cap. Flow %
-1.21%
Top 10 Hldgs %
100%
Holding
11
New
1
Increased
4
Reduced
5
Closed
1

Top Buys

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$404M
2
MSFT icon
Microsoft
MSFT
+$186M
3
TRU icon
TransUnion
TRU
+$177M
4
V icon
Visa
V
+$89M
5
CRM icon
Salesforce
CRM
+$52.7M

Top Sells

Rank Stock Value
1
TJX icon
TJX Companies
TJX
+$415M
2
FISV
Fiserv Inc
FISV
+$212M
3
A icon
Agilent Technologies
A
+$140M
4
ADBE icon
Adobe
ADBE
+$120M
5
MA icon
Mastercard
MA
+$46.9M

Sector Composition

Rank Sector Weight
1 Technology 46.97%
2 Financials 39.21%
3 Healthcare 13.82%
4 Consumer Discretionary 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
V icon
1
Visa
V
$684B
$923M 16.81%
4,011,538
+370,122
+10% +$89M
MSFT icon
2
Microsoft
MSFT
$3.42T
$850M 15.48%
2,690,673
+562,722
+26% +$186M
FISV
3
Fiserv Inc
FISV
$28.6B
$644M 11.73%
5,701,555
-1,718,242
-23% -$212M
MA icon
4
Mastercard
MA
$507B
$635M 11.58%
1,604,921
-116,935
-7% -$46.9M
CRM icon
5
Salesforce
CRM
$150B
$599M 10.91%
2,952,995
+243,789
+9% +$52.7M
TRU icon
6
TransUnion
TRU
$15.1B
$594M 10.82%
8,274,319
+2,255,384
+37% +$177M
ADBE icon
7
Adobe
ADBE
$99.3B
$486M 8.85%
952,424
-227,911
-19% -$120M
TMO icon
8
Thermo Fisher Scientific
TMO
$213B
$383M 6.99%
+757,625
New +$404M
ICLR icon
9
Icon
ICLR
$12.9B
$241M 4.39%
977,914
-163,992
-14% -$41.3M
A icon
10
Agilent Technologies
A
$39.2B
$135M 2.45%
1,202,885
-1,165,999
-49% -$140M
TJX icon
11
TJX Companies
TJX
$174B
-4,896,496
Closed -$415M

Similar funds

BlueSpruce Investments's Q3 2023 Portfolio in Review

As of Q3 2023, BlueSpruce Investments held 11 positions worth $5.49B, down 5.5% from $5.81B the previous quarter. Its ten largest holdings account for 100% of the portfolio.

BlueSpruce Investments's Q3 2023 filing shows 1 new, 4 increased, 5 reduced and 1 closed positions. Its largest new stake was Thermo Fisher Scientific: 757,625 shares worth $383M. The largest sale was TJX Companies, an estimated $415M.

By sector, the portfolio is most concentrated in Technology at 47% of assets, down from 48% a quarter earlier, followed by Financials and Healthcare.

  • BlueSpruce Investments's largest Q3 2023 buy was Thermo Fisher Scientific: 757,625 shares worth $383M.
  • BlueSpruce Investments added most to Microsoft in Q3 2023, an estimated $186M increase.
  • BlueSpruce Investments's biggest Q3 2023 reduction was Fiserv Inc, cutting an estimated $212M.
  • BlueSpruce Investments fully exited TJX Companies in Q3 2023, selling an estimated $415M.
  • BlueSpruce Investments's ten largest holdings make up 100% of its $5.49B portfolio in Q3 2023.
  • BlueSpruce Investments opened 1 new position and closed 1 in Q3 2023.
  • BlueSpruce Investments's portfolio value fell 5.5% quarter-over-quarter to $5.49B.

Based on BlueSpruce Investments's 13F filing for Q3 2023, filed 14 Nov 2023.